Efficacy and safety of a fixed dose combination of glimepiride and sustained release metformin in Indian patients with type 2 diabetes mellitus

被引：0
|
作者：
Desai, AA
Singh, KP
Rajadhyaksha, GC
Anandmoses, CR
Ballary, CC
Gawde, AS
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A474 / A474
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of glimepiride (GLIM) in patients with type 2 diabetes uncontrolled on metformin (MET)/thiazolidinedione (TZD) combination therapy
    Roberts, VL
    Stewart, J
    Issa, M
    Lake, B
    Melis, R
    DIABETES, 2004, 53 : A144 - A144
  • [22] Evaluation of Efficacy and Tolerability of Glimepiride and Metformin Combination: A Multicentric Study in Patients with Type-2 Diabetes Mellitus, Uncontrolled on Monotherapy with Sulfonylurea or Metformin
    Pareek, Anil
    Chandurkar, Nitin B.
    Salkar, Harsha R.
    Borkar, Mangala S.
    Tiwari, Dharmendra
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (01) : 41 - 47
  • [23] Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus
    Guo, Xiao-hui
    Lv, Xiao-feng
    Han, Ping
    Zhang, Xiu-zhen
    Yang, Hua-zhang
    Duan, Wen-ruo
    Gao, Yan
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (03) : 169 - 174
  • [24] Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
    Ametov, A. S.
    Abaeva, F. A.
    DIABETES MELLITUS, 2013, 16 (04): : 95 - 100
  • [25] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
    Hermansen, K.
    Kipnes, M.
    Luo, E.
    Fanurik, D.
    Khatami, H.
    Stein, P.
    DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 733 - 745
  • [26] Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India
    Sahay, Rakesh
    Gangwani, Dinesh
    Singh, Manish
    Gupta, Sandeep
    Kale, Narendra
    Srivastava, Manoj
    Kurmi, Prakash
    Ambaliya, Jayesh
    Lomte, Nilesh
    Gofne, Sandip
    Agarwal, Saurabh
    Kashid, Priyanka
    Agarwal, Vikas
    Rai, Pradeep
    Sharma, Surendra
    Murthy, L. Sreenivasa
    Rajurkar, Mandodari
    Saha, Shruti
    Patel, Piyush
    Patil, Dipak
    Ghadge, Pravin
    Lakhwani, Lalit
    Mehta, Suyog
    Joglekar, Sadhna J.
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2193 - 2205
  • [27] Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
    Xie, Jing
    Li, Ning
    Jiang, Xiaoyan
    Chai, Liyin
    Chen, Jian-Jun
    Deng, Wuquan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2019, 12 : 519 - 526
  • [28] A Multicenter, Phase III Evaluation of the Efficacy and Safety of a New Fixed-Dose Pioglitazone/Glimepiride Combination Tablet in Japanese Patients with Type 2 Diabetes
    Hiroi, Shinzo
    Sugiura, Kenkichi
    Matsuno, Kumi
    Hirayama, Masashi
    Kuriyama, Kenji
    Kaku, Kohei
    Kawakami, Koji
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (02) : 158 - 165
  • [29] Sitagliptin/Metformin Fixed-Dose CombinationIn Patients with Type 2 Diabetes Mellitus
    Claudine M. Chwieduk
    Drugs, 2011, 71 : 349 - 361
  • [30] Sitagliptin/Metformin Fixed-Dose Cambination In Patients with Type 2 Diabetes Mellitus
    Chwieduk, Claudine M.
    DRUGS, 2011, 71 (03) : 349 - 361
12345